The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Primary Antibodies-Global Market Insights and Sales Trends 2025

Primary Antibodies-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1837254

No of Pages : 117

Ask Your Query
Synopsis
The global Primary Antibodies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Primary Antibodies in various end use industries. The expanding demands from the ELISA, Western Blot, Immunostaining and Immunohistochemistry, are propelling Primary Antibodies market. Polyclonal, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Primary Antibodies market, driven by demand from China, the second largest economy with some signs of stabilising, the Primary Antibodies market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Primary Antibodies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Primary Antibodies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Primary Antibodies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Primary Antibodies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Primary Antibodies covered in this report include Abcam, BD, Santa Cruz Biotechnology, Sigma Aldrich Corporation, Thermo Fisher Scientific, Bio-Rad, R&D Systems, MBL and CST, etc.
The global Primary Antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abcam
BD
Santa Cruz Biotechnology
Sigma Aldrich Corporation
Thermo Fisher Scientific
Bio-Rad
R&D Systems
MBL
CST
Merk
Novus Biologicals
PeproTech
Cayman
AbMax Biotechnology
MABTech
KPL
Abnova
Global Primary Antibodies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Primary Antibodies market, Segment by Type:
Polyclonal
Monoclonal
Global Primary Antibodies market, by Application
ELISA
Western Blot
Immunostaining
Immunohistochemistry
Immunocytochemistry
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Primary Antibodies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Primary Antibodies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Primary Antibodies Market Overview
1.1 Primary Antibodies Product Overview
1.2 Primary Antibodies Market Segment by Type
1.2.1 Polyclonal
1.2.2 Monoclonal
1.3 Global Primary Antibodies Market Size by Type
1.3.1 Global Primary Antibodies Market Size Overview by Type (2018-2029)
1.3.2 Global Primary Antibodies Historic Market Size Review by Type (2018-2023)
1.3.3 Global Primary Antibodies Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Primary Antibodies Sales Breakdown by Type (2018-2023)
1.4.2 Europe Primary Antibodies Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Primary Antibodies Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Primary Antibodies Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Primary Antibodies Sales Breakdown by Type (2018-2023)
2 Global Primary Antibodies Market Competition by Company
2.1 Global Top Players by Primary Antibodies Sales (2018-2023)
2.2 Global Top Players by Primary Antibodies Revenue (2018-2023)
2.3 Global Top Players by Primary Antibodies Price (2018-2023)
2.4 Global Top Manufacturers Primary Antibodies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Primary Antibodies Market Competitive Situation and Trends
2.5.1 Primary Antibodies Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Primary Antibodies Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Primary Antibodies as of 2022)
2.7 Date of Key Manufacturers Enter into Primary Antibodies Market
2.8 Key Manufacturers Primary Antibodies Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Primary Antibodies Status and Outlook by Region
3.1 Global Primary Antibodies Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Primary Antibodies Historic Market Size by Region
3.2.1 Global Primary Antibodies Sales in Volume by Region (2018-2023)
3.2.2 Global Primary Antibodies Sales in Value by Region (2018-2023)
3.2.3 Global Primary Antibodies Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Primary Antibodies Forecasted Market Size by Region
3.3.1 Global Primary Antibodies Sales in Volume by Region (2024-2029)
3.3.2 Global Primary Antibodies Sales in Value by Region (2024-2029)
3.3.3 Global Primary Antibodies Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Primary Antibodies by Application
4.1 Primary Antibodies Market Segment by Application
4.1.1 ELISA
4.1.2 Western Blot
4.1.3 Immunostaining
4.1.4 Immunohistochemistry
4.1.5 Immunocytochemistry
4.1.6 Other
4.2 Global Primary Antibodies Market Size by Application
4.2.1 Global Primary Antibodies Market Size Overview by Application (2018-2029)
4.2.2 Global Primary Antibodies Historic Market Size Review by Application (2018-2023)
4.2.3 Global Primary Antibodies Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Primary Antibodies Sales Breakdown by Application (2018-2023)
4.3.2 Europe Primary Antibodies Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Primary Antibodies Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Primary Antibodies Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Primary Antibodies Sales Breakdown by Application (2018-2023)
5 North America Primary Antibodies by Country
5.1 North America Primary Antibodies Historic Market Size by Country
5.1.1 North America Primary Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Primary Antibodies Sales in Volume by Country (2018-2023)
5.1.3 North America Primary Antibodies Sales in Value by Country (2018-2023)
5.2 North America Primary Antibodies Forecasted Market Size by Country
5.2.1 North America Primary Antibodies Sales in Volume by Country (2024-2029)
5.2.2 North America Primary Antibodies Sales in Value by Country (2024-2029)
6 Europe Primary Antibodies by Country
6.1 Europe Primary Antibodies Historic Market Size by Country
6.1.1 Europe Primary Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Primary Antibodies Sales in Volume by Country (2018-2023)
6.1.3 Europe Primary Antibodies Sales in Value by Country (2018-2023)
6.2 Europe Primary Antibodies Forecasted Market Size by Country
6.2.1 Europe Primary Antibodies Sales in Volume by Country (2024-2029)
6.2.2 Europe Primary Antibodies Sales in Value by Country (2024-2029)
7 Asia-Pacific Primary Antibodies by Region
7.1 Asia-Pacific Primary Antibodies Historic Market Size by Region
7.1.1 Asia-Pacific Primary Antibodies Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Primary Antibodies Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Primary Antibodies Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Primary Antibodies Forecasted Market Size by Region
7.2.1 Asia-Pacific Primary Antibodies Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Primary Antibodies Sales in Value by Region (2024-2029)
8 Latin America Primary Antibodies by Country
8.1 Latin America Primary Antibodies Historic Market Size by Country
8.1.1 Latin America Primary Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Primary Antibodies Sales in Volume by Country (2018-2023)
8.1.3 Latin America Primary Antibodies Sales in Value by Country (2018-2023)
8.2 Latin America Primary Antibodies Forecasted Market Size by Country
8.2.1 Latin America Primary Antibodies Sales in Volume by Country (2024-2029)
8.2.2 Latin America Primary Antibodies Sales in Value by Country (2024-2029)
9 Middle East and Africa Primary Antibodies by Country
9.1 Middle East and Africa Primary Antibodies Historic Market Size by Country
9.1.1 Middle East and Africa Primary Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Primary Antibodies Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Primary Antibodies Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Primary Antibodies Forecasted Market Size by Country
9.2.1 Middle East and Africa Primary Antibodies Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Primary Antibodies Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abcam
10.1.1 Abcam Company Information
10.1.2 Abcam Introduction and Business Overview
10.1.3 Abcam Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abcam Primary Antibodies Products Offered
10.1.5 Abcam Recent Development
10.2 BD
10.2.1 BD Company Information
10.2.2 BD Introduction and Business Overview
10.2.3 BD Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.2.4 BD Primary Antibodies Products Offered
10.2.5 BD Recent Development
10.3 Santa Cruz Biotechnology
10.3.1 Santa Cruz Biotechnology Company Information
10.3.2 Santa Cruz Biotechnology Introduction and Business Overview
10.3.3 Santa Cruz Biotechnology Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Santa Cruz Biotechnology Primary Antibodies Products Offered
10.3.5 Santa Cruz Biotechnology Recent Development
10.4 Sigma Aldrich Corporation
10.4.1 Sigma Aldrich Corporation Company Information
10.4.2 Sigma Aldrich Corporation Introduction and Business Overview
10.4.3 Sigma Aldrich Corporation Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sigma Aldrich Corporation Primary Antibodies Products Offered
10.4.5 Sigma Aldrich Corporation Recent Development
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Company Information
10.5.2 Thermo Fisher Scientific Introduction and Business Overview
10.5.3 Thermo Fisher Scientific Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Thermo Fisher Scientific Primary Antibodies Products Offered
10.5.5 Thermo Fisher Scientific Recent Development
10.6 Bio-Rad
10.6.1 Bio-Rad Company Information
10.6.2 Bio-Rad Introduction and Business Overview
10.6.3 Bio-Rad Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bio-Rad Primary Antibodies Products Offered
10.6.5 Bio-Rad Recent Development
10.7 R&D Systems
10.7.1 R&D Systems Company Information
10.7.2 R&D Systems Introduction and Business Overview
10.7.3 R&D Systems Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.7.4 R&D Systems Primary Antibodies Products Offered
10.7.5 R&D Systems Recent Development
10.8 MBL
10.8.1 MBL Company Information
10.8.2 MBL Introduction and Business Overview
10.8.3 MBL Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.8.4 MBL Primary Antibodies Products Offered
10.8.5 MBL Recent Development
10.9 CST
10.9.1 CST Company Information
10.9.2 CST Introduction and Business Overview
10.9.3 CST Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.9.4 CST Primary Antibodies Products Offered
10.9.5 CST Recent Development
10.10 Merk
10.10.1 Merk Company Information
10.10.2 Merk Introduction and Business Overview
10.10.3 Merk Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Merk Primary Antibodies Products Offered
10.10.5 Merk Recent Development
10.11 Novus Biologicals
10.11.1 Novus Biologicals Company Information
10.11.2 Novus Biologicals Introduction and Business Overview
10.11.3 Novus Biologicals Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Novus Biologicals Primary Antibodies Products Offered
10.11.5 Novus Biologicals Recent Development
10.12 PeproTech
10.12.1 PeproTech Company Information
10.12.2 PeproTech Introduction and Business Overview
10.12.3 PeproTech Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.12.4 PeproTech Primary Antibodies Products Offered
10.12.5 PeproTech Recent Development
10.13 Cayman
10.13.1 Cayman Company Information
10.13.2 Cayman Introduction and Business Overview
10.13.3 Cayman Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Cayman Primary Antibodies Products Offered
10.13.5 Cayman Recent Development
10.14 AbMax Biotechnology
10.14.1 AbMax Biotechnology Company Information
10.14.2 AbMax Biotechnology Introduction and Business Overview
10.14.3 AbMax Biotechnology Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.14.4 AbMax Biotechnology Primary Antibodies Products Offered
10.14.5 AbMax Biotechnology Recent Development
10.15 MABTech
10.15.1 MABTech Company Information
10.15.2 MABTech Introduction and Business Overview
10.15.3 MABTech Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.15.4 MABTech Primary Antibodies Products Offered
10.15.5 MABTech Recent Development
10.16 KPL
10.16.1 KPL Company Information
10.16.2 KPL Introduction and Business Overview
10.16.3 KPL Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.16.4 KPL Primary Antibodies Products Offered
10.16.5 KPL Recent Development
10.17 Abnova
10.17.1 Abnova Company Information
10.17.2 Abnova Introduction and Business Overview
10.17.3 Abnova Primary Antibodies Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Abnova Primary Antibodies Products Offered
10.17.5 Abnova Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Primary Antibodies Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Primary Antibodies Industrial Chain Analysis
11.4 Primary Antibodies Market Dynamics
11.4.1 Primary Antibodies Industry Trends
11.4.2 Primary Antibodies Market Drivers
11.4.3 Primary Antibodies Market Challenges
11.4.4 Primary Antibodies Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Primary Antibodies Distributors
12.3 Primary Antibodies Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock